Shanghai Shen Lian Biomedical Corp
SSE:688098

Watchlist Manager
Shanghai Shen Lian Biomedical Corp Logo
Shanghai Shen Lian Biomedical Corp
SSE:688098
Watchlist
Price: 9.33 CNY 1.3% Market Closed
Market Cap: 3.8B CNY
Section:
 

Relative Value

The Relative Value of one Shanghai Shen Lian Biomedical Corp stock under the Base Case scenario is hidden CNY. Compared to the current market price of 9.33 CNY, Shanghai Shen Lian Biomedical Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shanghai Shen Lian Biomedical Corp Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

13
P/S
P/S
Price to Sales
13
vs History
26
vs Industry
17
Median 3Y
9.7
Median 5Y
10.1
Industry
2.6
Forward
5.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
4
Median 3Y
-49.3
Median 5Y
40.7
Industry
21.4
Forward
18
More Details
45
P/OCF
P/OCF
Price to OCF
45
vs History
52
vs Industry
Median 3Y
40.9
Median 5Y
44.5
Industry
16.4
More Details
5 578.5
P/FCFE
P/FCFE
Price to FCFE
5 578.5
vs History
6
vs Industry
Median 3Y
22.6
Median 5Y
-32
Industry
22.8
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
31
vs Industry
47
Median 3Y
2
Median 5Y
2.2
Industry
2.2
More Details
13.1
EV/S
EV/S
Enterprise Value to Sales
13.1
vs History
25
vs Industry
17
Median 3Y
8.9
Median 5Y
9.3
Industry
2.9
Forward
5.8
More Details
22.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
22.5
vs History
7
vs Industry
19
Median 3Y
12.9
Median 5Y
13.3
Industry
5.5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
3
Median 3Y
-37.2
Median 5Y
35
Industry
13
Forward
9.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
4
Median 3Y
-37.2
Median 5Y
35
Industry
16.5
More Details
45.2
EV/OCF
EV/OCF
Enterprise Value to OCF
45.2
vs History
46
vs Industry
Median 3Y
41.1
Median 5Y
43
Industry
15.6
More Details
5 599.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
5 599.2
vs History
6
vs Industry
Median 3Y
20.2
Median 5Y
-29.4
Industry
18.7
More Details
2.5
EV/IC
EV/IC
Enterprise Value to IC
2.5
vs History
41
vs Industry
43
Median 3Y
2
Median 5Y
2.3
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai Shen Lian Biomedical Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Shen Lian Biomedical Corp
SSE:688098
3.8B CNY 13 -84.2 -62.9 -62.9
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.9 38.1 40.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
499.3B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
269.3B CHF 4.4 28.6 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
220.6B GBP 5.1 31.6 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
270.1B USD 4.2 14.2 10.1 11.9
CH
Novartis AG
SIX:NOVN
218B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 10.9 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
CN
Shanghai Shen Lian Biomedical Corp
SSE:688098
Average P/E: 25.1
Negative Multiple: -84.2 		N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.9
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.6
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.6
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Shanghai Shen Lian Biomedical Corp
SSE:688098
Average EV/EBITDA: 440.1
Negative Multiple: -62.9 		N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.1
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Shanghai Shen Lian Biomedical Corp
SSE:688098
Average EV/EBIT: 1 883.7
Negative Multiple: -62.9 		N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.9
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.